Skip to main content
Top
Published in: Inflammation Research 1/2011

01-01-2011 | History of inflammation

Sir James Black and the European Histamine Research Society

Author: Anita Sydbom

Published in: Inflammation Research | Issue 1/2011

Login to get access

Excerpt

I first met Sir James Black at the International Pharmacology Meeting in Helsinki in 1975. I was a young PhD student in my very first years and had the honour to be seated next to him at a dinner banquet. He was very kind and amusing and gave me lots of friendly advice for my work and experiments. Later I was also given some samples of the H2 blockers, burimamide and metiamide, to test in my system with rat isolated mast cells. …
Literature
2.
go back to reference Sjöqvist F. The Nobel Prize in Physiology or Medicine 1988. In: Frängsmyr T, Lindsten J (eds) Presentation Speech Nobel Lectures, Physiology or Medicine 1981–1990. Singapore: World Scientific; 1993. Sjöqvist F. The Nobel Prize in Physiology or Medicine 1988. In: Frängsmyr T, Lindsten J (eds) Presentation Speech Nobel Lectures, Physiology or Medicine 1981–1990. Singapore: World Scientific; 1993.
4.
go back to reference Black JW. The Nobel Prize in Physiology or Medicine 1988. In: Frängsmyr T (ed) Autobiography Les Prix Nobel. The Nobel Prizes 1988. Stockholm: Nobel Foundation; 1989. Black JW. The Nobel Prize in Physiology or Medicine 1988. In: Frängsmyr T (ed) Autobiography Les Prix Nobel. The Nobel Prizes 1988. Stockholm: Nobel Foundation; 1989.
Metadata
Title
Sir James Black and the European Histamine Research Society
Author
Anita Sydbom
Publication date
01-01-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 1/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-010-0270-9

Other articles of this Issue 1/2011

Inflammation Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.